Arthrex’s ACL TightRope Implant Receives the US FDA’s Clearance for Anterior Cruciate Ligament Reconstruction
Shots:
- The US FDA has cleared ACL TightRope, a first fixation device for use in treating pediatric ACL injuries. The device was developed with the Hospital for Special Surgery for use in a high-risk group of young athletes & helps to develop minimally invasive solutions
- The company worked with orthopedic surgeons from the HSS & developed an all-epiphyseal technique for skeletally immature patients that involves reducing the risk of damaging the growth plates while ensuring proper fixation & strength using pediatric-specific instrumentation to drill sockets for ACL graft
- The ACL TightRope portfolio of fixation devices incl. the ACL TightRope II implant, the TightRope ABS and implant, the FiberTag & the ACL Repair TightRope implant with FiberRing sutures
Ref: PR Newswire | Image: Arthrex
Click here to read the full press release
Tags
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
